What is c-peptide?

C-peptide is a protein released alongside insulin that serves as a reliable marker of your body's natural insulin production. Testing C-peptide levels helps diagnose diabetes types, monitor pancreatic function, and guide treatment decisions.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding C-Peptide: The Insulin Production Marker

C-peptide, short for connecting peptide, is a crucial biomarker that provides valuable insights into your body's insulin production. When your pancreas produces insulin, it starts with a larger molecule called proinsulin. This proinsulin is then split into two equal parts: insulin and C-peptide. Both are released into your bloodstream in equal amounts, making C-peptide an excellent indicator of how much insulin your body naturally produces.

Unlike insulin, which is quickly used by cells or cleared from the bloodstream, C-peptide remains in circulation longer and is more stable. This stability makes it a more reliable marker for assessing pancreatic function, especially in people who take insulin injections. While insulin tests can be affected by external insulin administration, C-peptide levels reflect only the insulin your body produces naturally.

Understanding your C-peptide levels can provide critical information about your metabolic health, help differentiate between types of diabetes, and guide treatment decisions. Regular monitoring of C-peptide alongside other metabolic markers can help you maintain optimal health and catch potential issues early.

C-Peptide Level Interpretation Guide

C-Peptide LevelCategoryClinical SignificanceCommon Conditions
<0.5 ng/mL<0.5 ng/mLLowReduced insulin productionType 1 diabetes, late-stage Type 2, pancreatic damage
0.5-2.0 ng/mL0.5-2.0 ng/mLNormalHealthy insulin productionNormal metabolic function
2.1-3.0 ng/mL2.1-3.0 ng/mLElevatedIncreased insulin productionEarly Type 2 diabetes, insulin resistance, metabolic syndrome
>3.0 ng/mL>3.0 ng/mLHighExcessive insulin productionInsulinoma, kidney disease, severe insulin resistance

C-peptide levels should be interpreted alongside glucose levels and clinical symptoms for accurate diagnosis.

Why C-Peptide Testing Matters

C-peptide testing serves multiple important purposes in healthcare. For individuals with diabetes, it helps determine whether their pancreas is still producing insulin, which is crucial for choosing the right treatment approach. In Type 1 diabetes, the immune system destroys insulin-producing beta cells, leading to very low or undetectable C-peptide levels. In Type 2 diabetes, C-peptide levels may be normal or even elevated initially, as the pancreas works harder to overcome insulin resistance.

Beyond diabetes diagnosis, C-peptide testing can help identify other conditions affecting insulin production. It can detect insulinomas (insulin-producing tumors), assess pancreatic function after surgery, and help differentiate between various causes of hypoglycemia. For people without diabetes, monitoring C-peptide levels can provide early warning signs of metabolic dysfunction before blood sugar problems become apparent.

Differentiating Diabetes Types

One of the most valuable applications of C-peptide testing is distinguishing between Type 1 and Type 2 diabetes, especially in cases where the diagnosis isn't clear. Adults who develop diabetes may have either type, and C-peptide levels can clarify which form they have. This distinction is crucial because treatment approaches differ significantly between the two types.

Monitoring Treatment Effectiveness

For people with Type 2 diabetes, C-peptide levels can indicate how well their pancreas is functioning over time. Declining C-peptide levels may suggest that oral medications are becoming less effective and that insulin therapy might be needed. This information helps healthcare providers make timely adjustments to treatment plans.

Normal C-Peptide Ranges and What They Mean

C-peptide levels are typically measured in nanograms per milliliter (ng/mL) or nanomoles per liter (nmol/L). Normal fasting C-peptide levels generally range from 0.5 to 2.0 ng/mL (0.17 to 0.67 nmol/L), though these ranges can vary slightly between laboratories. After eating, C-peptide levels naturally rise as your pancreas releases insulin to process the incoming glucose.

Low C-peptide levels (below 0.5 ng/mL) typically indicate reduced insulin production. This can occur in Type 1 diabetes, late-stage Type 2 diabetes, or pancreatic disorders. Very low or undetectable levels strongly suggest Type 1 diabetes or significant pancreatic damage.

High C-peptide levels (above 2.0 ng/mL fasting) often indicate insulin resistance, where the pancreas produces extra insulin to compensate for cells not responding properly. This is common in early Type 2 diabetes, metabolic syndrome, and obesity. Extremely high levels might suggest an insulinoma or kidney disease, as the kidneys normally clear C-peptide from the blood.

Factors That Affect C-Peptide Levels

Several factors can influence your C-peptide levels beyond pancreatic function. Understanding these factors is important for accurate interpretation of test results.

Dietary and Lifestyle Factors

What you eat significantly impacts C-peptide levels. High-carbohydrate meals stimulate more insulin and C-peptide release than low-carb meals. Fasting or very low-calorie diets can temporarily lower C-peptide levels. Regular exercise improves insulin sensitivity, which may lead to lower C-peptide levels over time as your body becomes more efficient at using insulin.

Medical Conditions and Medications

Kidney disease can elevate C-peptide levels because the kidneys are responsible for clearing it from the blood. Certain medications, including corticosteroids and some diabetes drugs, can affect C-peptide production. Autoimmune conditions beyond Type 1 diabetes may also impact pancreatic function and C-peptide levels.

Timing and Testing Conditions

The timing of your C-peptide test matters significantly. Fasting tests provide baseline levels, while stimulated tests (after a meal or glucose drink) show how well your pancreas responds to rising blood sugar. Some doctors use a mixed-meal tolerance test or glucagon stimulation test to assess pancreatic reserve more accurately.

C-Peptide Testing Methods and Interpretation

C-peptide testing typically requires a blood sample, though urine tests are sometimes used for 24-hour C-peptide measurements. The most common approach is a fasting blood test, where you avoid food for 8-12 hours before the sample is taken. This provides your baseline C-peptide level without the influence of recent meals.

For a more comprehensive assessment, doctors may order a stimulated C-peptide test. This involves consuming a standardized meal or glucose drink, then measuring C-peptide levels at specific intervals. This shows not just your baseline production but how well your pancreas responds to rising blood sugar. Some providers also measure C-peptide alongside glucose and insulin for a complete picture of metabolic function.

Interpreting C-peptide results requires considering the clinical context. A single low reading doesn't necessarily mean Type 1 diabetes, just as a single high reading doesn't confirm insulin resistance. Trends over time and correlation with other markers like glucose, HbA1c, and insulin provide the most valuable insights.

Clinical Applications Beyond Diabetes

While C-peptide testing is most commonly associated with diabetes, it has several other important clinical applications. In cases of unexplained hypoglycemia, C-peptide levels can help determine whether excess insulin is coming from the body (high C-peptide) or from external sources like insulin injections (low C-peptide). This distinction is crucial for diagnosing conditions like insulinomas or factitious hypoglycemia.

C-peptide testing also plays a role in pancreatic transplant monitoring. After a successful pancreatic or islet cell transplant, rising C-peptide levels indicate that the transplanted tissue is producing insulin. Regular monitoring helps assess transplant function and guide immunosuppressive therapy.

In research settings, C-peptide is used to evaluate new diabetes treatments. Clinical trials for drugs aimed at preserving or restoring beta cell function often use C-peptide levels as a primary outcome measure. This helps researchers understand whether treatments are actually improving the body's natural insulin production capacity.

Optimizing Your C-Peptide Levels Naturally

While you cannot directly control C-peptide production, you can support healthy pancreatic function through lifestyle choices. These strategies can help maintain optimal insulin production and sensitivity, reflected in balanced C-peptide levels.

Dietary Strategies

Focus on whole, unprocessed foods that don't cause rapid blood sugar spikes. Include plenty of fiber-rich vegetables, lean proteins, and healthy fats in your meals. These nutrients slow glucose absorption and reduce the demand on your pancreas. Limiting refined sugars and processed carbohydrates helps prevent the insulin resistance that leads to elevated C-peptide levels.

  • Choose complex carbohydrates over simple sugars
  • Include protein with every meal to stabilize blood sugar
  • Eat plenty of non-starchy vegetables for fiber and nutrients
  • Consider intermittent fasting to improve insulin sensitivity
  • Stay hydrated to support overall metabolic function

Exercise and Physical Activity

Regular physical activity is one of the most effective ways to improve insulin sensitivity and support healthy C-peptide levels. Both aerobic exercise and resistance training offer benefits. Aim for at least 150 minutes of moderate-intensity exercise per week, along with two or more strength training sessions. Even simple activities like walking after meals can help improve glucose metabolism.

Stress Management and Sleep

Chronic stress and poor sleep both negatively impact insulin sensitivity and pancreatic function. Prioritize getting 7-9 hours of quality sleep each night and develop effective stress management techniques. Practices like meditation, yoga, or deep breathing exercises can help regulate stress hormones that interfere with insulin production and action.

Taking Action: Monitoring Your Metabolic Health

Understanding your C-peptide levels is just one piece of the metabolic health puzzle. Regular monitoring of C-peptide alongside other key biomarkers provides a comprehensive view of your metabolic function and helps identify potential issues before they become serious health problems. This proactive approach allows you to make informed decisions about your diet, exercise, and overall lifestyle to maintain optimal health.

Whether you're managing diabetes, investigating unexplained symptoms, or simply optimizing your health, C-peptide testing offers valuable insights into your body's insulin production. By understanding what C-peptide is and what your levels mean, you can work with your healthcare provider to develop a personalized approach to metabolic health. Regular testing and monitoring empower you to take control of your health journey and make evidence-based decisions for long-term wellness.

References

  1. Jones, A. G., & Hattersley, A. T. (2013). The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabetic Medicine, 30(7), 803-817.[Link][PubMed][DOI]
  2. Leighton, E., Sainsbury, C. A., & Jones, G. C. (2017). A practical review of C-peptide testing in diabetes. Diabetes Therapy, 8(3), 475-487.[Link][PubMed][DOI]
  3. Palmer, J. P., Fleming, G. A., Greenbaum, C. J., et al. (2004). C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function. Diabetes, 53(1), 250-264.[Link][PubMed][DOI]
  4. Little, R. R., & Rohlfing, C. L. (2013). The long and winding road to optimal HbA1c measurement. Clinica Chimica Acta, 418, 63-71.[PubMed][DOI]
  5. Berger, B., Stenström, G., & Sundkvist, G. (2000). Random C-peptide in the classification of diabetes. Scandinavian Journal of Clinical and Laboratory Investigation, 60(8), 687-693.[PubMed][DOI]
  6. Greenbaum, C. J., Mandrup-Poulsen, T., McGee, P. F., et al. (2008). Mixed-meal tolerance test versus glucagon stimulation test for the assessment of β-cell function in therapeutic trials in type 1 diabetes. Diabetes Care, 31(10), 1966-1971.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my C-peptide at home?

You can test your C-peptide at home with SiPhox Health's Core Health Program or Heart & Metabolic Program. Both CLIA-certified programs include C-peptide testing along with other essential metabolic markers, providing lab-quality results from the comfort of your home.

What is the normal range for C-peptide?

Normal fasting C-peptide levels typically range from 0.5 to 2.0 ng/mL (0.17 to 0.67 nmol/L). After eating, levels naturally rise as your pancreas releases insulin. Values below 0.5 ng/mL suggest reduced insulin production, while values above 2.0 ng/mL may indicate insulin resistance.

How is C-peptide different from insulin testing?

While both are released in equal amounts, C-peptide remains in the bloodstream longer and isn't affected by injected insulin. This makes C-peptide a more reliable marker of your body's natural insulin production, especially important for people taking insulin medications.

Can C-peptide levels be improved naturally?

Yes, you can support healthy C-peptide levels through lifestyle changes. Regular exercise, a balanced diet low in refined sugars, adequate sleep, and stress management all help improve insulin sensitivity and support optimal pancreatic function.

Why would my doctor order a C-peptide test?

Doctors order C-peptide tests to differentiate between Type 1 and Type 2 diabetes, assess remaining pancreatic function, investigate unexplained low blood sugar, monitor diabetes progression, or evaluate the need for insulin therapy.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details